654055-80-8Relevant articles and documents
Investigation of novel fumagillin analogues as angiogenesis inhibitors
Pyun, Hyung-Jung,Fardis, Maria,Tario, James,Yang, Cheng Y.,Ruckman, Judy,Henninger, Dwight,Jin, Haolun,Kim, Choung U.
, p. 91 - 94 (2007/10/03)
Modification of fumagillin was conducted to develop MetAP-2 inhibitors with desirable pharmacological properties. Replacement of the C4 side chain by benzyloxime preserves the inhibitory activity against MetAP-2 enzyme. Fumagillin analogues containing the